1. Partnership Overview & Global Regulatory Compliance Framework
As a reliable China-based full-lifecycle turnkey bioprocess engineering partner for global clients, we deliver fully integrated, single-source biomanufacturing plant solutions complying with FDA cGMP, EMA Annex 1, PIC/S harmonized GMP and ICH Q8/Q9/Q10 quality risk management standards. Our full turnkey scope covers pre-project consultation, conceptual & detailed engineering design, sanitary equipment manufacturing, cleanroom construction, MEP & utility integration, automation deployment, full CQV qualification and final audit-ready handover. Serving monoclonal antibodies, recombinant proteins, ADCs, viral vectors and vaccine manufacturing projects worldwide, we resolve typical cross-border pain points including fragmented multi-vendor coordination, mismatched design and global GMP standards, delayed document delivery, inconsistent sanitary workmanship and insufficient post-handover compliance support. With mature overseas project execution experience and vertically integrated industrial capacity, we provide cost-effective, schedule-controlled and fully regulation-compliant turnkey bioprocess engineering solutions for international biotech startups, CMO operators and pharmaceutical groups.
2. Core Partnership Philosophy & Global Turnkey Advantages
Guided by process-driven facility design and risk-based full-lifecycle quality control, our turnkey partnership eliminates traditional separated EPC loopholes and unifies all engineering, manufacturing and compliance standards under one accountable team. We integrate China’s advanced biopharma equipment manufacturing capacity with Western international regulatory requirements, balancing high-standard GMP execution and optimized CAPEX/OPEX for global projects. All facility layout, sanitary specification, utility configuration and automation logic are embedded with upfront FMEA risk assessment, ensuring intrinsic contamination control, process determinism and batch consistency. Different from generic turnkey contractors focusing only on construction completion, we take bioprocess performance and long-term inspection readiness as core delivery targets, realizing seamless transformation from process design, hardware integration to GMP-compliant stable production. Our one-party full responsibility model simplifies client project management, reduces interface risks and shortens overall plant delivery and validation cycles for global market registration.
3. Four Integrated Turnkey Service Modules & Standard Deliverables
Our complete turnkey bioprocess engineering system consists of four interlocked full-lifecycle service modules covering end-to-end project delivery: regulatory-aligned engineering & design module, integrated equipment manufacturing & procurement module, GMP construction & system integration module, and commissioning qualification & audit handover module. The engineering & design module provides cross-border site master planning, process-centric cleanroom zoning, BIM 3D optimization, P&ID drafting and full set of DQ & contamination control strategy documents adapted to target international regulatory markets. The manufacturing & procurement module delivers self-produced ASME BPE-grade sanitary vessels, bioreactor systems, downstream purification skids and automated control platforms, with unified FAT verification and full material traceability certification. The construction & integration module executes standardized cleanroom enclosure, sanitary orbital welding, WFI/HVAC/CEP utility installation and cross-system linkage integration under strict GMP workmanship supervision. The commissioning & handover module completes SAT system debugging, full IQ/OQ/PQ qualification, electronic batch record configuration and English-version audit document sorting, achieving one-stop GMP-ready project delivery.
4. Global Application & Long-Term Strategic Partnership Support
Our turnkey bioprocess engineering partnership is widely applied in international greenfield biomanufacturing campuses, brownfield GMP compliance renovation, clinical pilot process platform construction and multi-product flexible CMO factory development across Asia, Europe, the Middle East, Africa and Latin America. All delivered facilities adopt modular scalable architecture, reserving flexible expansion interfaces for future process intensification, capacity upgrading and new biotherapeutic pipeline iteration. We provide sustainable long-term partnership support including global standard regulation updates, periodic facility compliance re-evaluation, overseas remote & on-site technical after-sales, regulatory pre-audit guidance and production operation GMP training. As a trustworthy Chinese turnkey engineering partner for global biopharma clients, we deliver stable, compliant and cost-effective biomanufacturing infrastructure, accelerate international drug registration and commercial launch, and build long-term win-win strategic cooperation for global biopharmaceutical industrialization.
